Sun Pharma extends rally, shares surge nearly 7% in 2 sessions -- what is driving the rally?
The stock in the last two sessions has gained nearly 7% on account of the acquisition announcement of Uractiv portfolio from Fiterman Pharma in Romania
Written By: Zee Business Video Team